As small molecule APIs become increasingly complex, longer synthetic pathways present new challenges for process chemists. Drug developers are turning to evolving tools to find reliable and efficient synthesis routes to produce small molecule APIs. This white paper outlines the advanced AI-Enabled Route Scouting Services offered by the Small Molecules division and how these tools empower better, more efficient development of innovative small molecule drugs.

Download to read more about:

  • Evolving challenges in small molecule API synthesis
  • Principles of retrosynthetic analysis and its value in drugmaking
  • How advanced retrosynthetic analysis tools enable more sophisticated and efficient drug development

 

 

You may also be interested in:
Drug Substance (API/HPAPI)
API Services
First-in-Human Services
Author(s):
Dr. Aaron Johnson
Cheminformatics Data Scientist
Simon Wagschal
Associate Director, Small Molecules R&D
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content
Latest briefing from the Knowledge Center
Used as thumbnail for Powder to Particles podcast.
Video
Small Molecule API & HPAPI Development Capacity
This video presents Lonza's capabilities, facility locations, and timelines to assist biopharma...
Webinar (on-demand)
Linking Rational Design and Material-Sparing Strategies for Enabled Intermediates and Their Drug...
The rapid development of enabled forms and formulations is crucial for tackling the challenges posed...
Spray Drying - Bend
White paper
Optimizing Spray-Dried Dispersion Processes Through Risk-Based Development
This executive summary explores a risk-based approach to process qualification, demonstrating how...
Webinar (on-demand)
Excipients for Respiratory Delivery of Biologics
Local administration of biologic Active Pharmaceutical Ingredients to the lung via inhalation has...
Spray Drying Bend
White paper
From Technology Selection to Final Drug Product
Many new active pharmaceutical ingredients (APIs) suffer from poor gastro-intestinal solubility in...
dry powder inhalation image
White paper
Dry Powder Vaccines to Improve Global Access and Pandemic Response
Many vaccines require cold chain storage and distribution, limiting their accessibility in...
front of Tampa building with flags
White paper
Micro-dosing: Navigating the Path from Development to Commercialization with Powder-in-Capsule...
Microdosing, a technique involving the administration of precise, minimal drug doses, can...
PBPK_scientist-in-lab-with-monitor
Webinar (on-demand)
Enabled Form Selection for Oral Drug Products Using a Combination of In-Silico Modeling and In-Vitro...
Many new drug candidates face the hurdle of low aqueous solubility, hindering their absorption and...
vial filler
Webinar (on-demand)
Flexible-Dose Development Strategies for Today's Clinical Landscape
This on-demand webinar explores the importance of dose-flexible manufacturing strategies in modern...
AI-Enabled Route Scouting Service Scientists
Webinar (on-demand)
Innovative AI-Driven Solutions to Address the Growing Complexity of APIs
The complexity of small molecule active pharmaceutical ingredients (APIs) is rising, bringing longer...
Lonza Bend Early Phase
e-book
Navigating Commercial Drug Development Technologies for Formulation Excellence
Our Small Molecule division is focused on leveraging its technologies and expertise to address...
Route scouting man with tablet
White paper
Powering Drug Development with Advanced Retrosynthetic Analysis Tools
As small molecule APIs become increasingly complex, longer synthetic pathways present new challenges...